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Resumo 
Os tumores das glândulas salivares são raros e constituem cerca de 3 a 6% de todos os 
tumores da cabeça e do pescoço. O adenoma pleomórfico, também conhecido por tumor 
misto, é uma neoplasia benigna e é o tumor mais comum das glândulas salivares. Este 
afecta maioritariamente as glândulas salivares major, mais especificamente a glândula 
parótida, e menos frequentemente as glândulas salivares minor. O palato é o local mais 
comum para a origem do tumor misto das glândulas salivares minor. Quanto mais 
pequena for a glândula salivar afectada, maior é a probabilidade de se malignizar. O seu 
pico de incidência ocorre entre os 40 e os 50 anos e é ligeiramente mais frequente no 
sexo feminino. Este tumor tem sido associado a alterações do cariótipo em cerca de 
70% dos casos. É descrito um caso clínico de um adenoma pleomórfico das glândulas 
salivares minor do palato mole, numa doente de 20 anos e do sexo feminino, que já 
apresentava um diâmetro crânio-caudal de 5 cm. 
Palavras-chave: Adenoma pleomórfico; tumor benigno; glândulas salivares minor; 
palato mole; excisão.  
 
Abstract 
Salivary gland tumors are rare and account for 3 to 6% of tumors occurring in the head 
and neck. Pleomorphic adenoma, also known as mixed tumor, is a benign neoplasm and 
it is the most common salivary gland tumor. It affects mostly the parotid gland and 
other major salivary glands, and less frequently the minor salivary glands. The palate is 
the most common site for mixed tumors of the minor salivary glands. The smaller the 
salivary gland that is affected, the more likely it is to trigger a malignant tumor. The 
incidence peak of pleomorphic adenoma is between 40 to 50 years of age and it is 
slightly more frequent in females. This tumor has been associated with abnormal 
karyotypes in up to 70% of cases. A case of a pleomorphic adenoma of the minor 
salivary glands of the soft palate in a 20 year-old female patient which had already 5 cm 
of cranio-caudal diameter is described. 









The salivary glands are divided into major 
and minor salivary gland categories. The major 
salivary glands are the parotid, the 
submandibular, and the sublingual glands. The 
minor glands are dispersed throughout the 
upper aerodigestive submucosa.  
Salivary gland neoplasms are uncommon 
and account for 3 to 6% of all head and neck 
tumors.
[1-4]
 They exhibit a wide range of benign 
and malignant histologic types. Most salivary 
gland tumors (SGTs) originate, by far, in the 
parotid gland (80%) 
[5,6]
, followed by the minor 
salivary glands (22%), submandibular (8%) and 
sublingual (1%) glands.
[1-3,7]
 Most SGTs are 
benign, nevertheless 25% of parotid tumors, 
45% of submandibular tumors, 80% of 
sublingual tumors and 75% of minor salivary 
gland tumors are malignant.
[1,5,6]
 
The most common malignant tumors are 
mucoepidermoid carcinoma, adenoid cystic 
carcinoma and polymorphous low-grade 
adenocarcinoma.  
The etiology of SGTs is so far unknown. 
Putative risk factors include cigarette smoking, 
viral infections, rubber manufacturing workers, 
genes etc. The only well-established risk factor 
is ionizing radiation.
[3,5,8,9]
 Genetic alterations, 
such as allelic loss, monosomy and polysomy, 
and structural rearrangement, have all been 




Pleomorphic adenoma (PA) is the most 
common benign tumor of the salivary glands, 
accounting for about 70% of all the salivary 
gland tumors.
[9,13,14]
 It affects mostly the 
parotid gland and other major salivary glands, 
less frequently the accessory glands. The 
majority of the minor gland PAs occur in the 
palate (55%) followed by the lip (25%), and a 
small minority are located in the buccal 
mucosa, floor of the mouth, tongue, pharynx, 
retromolar area, gingiva and nasal cavity.
[13,15-
17]
 Although PAs are classified as benign, they 
are frequently multinodular and may recur, can 
undergo malignant transformation and can even 
metastasize.
[8,11,14]
 The incidence peak of PA is 
between 40 to 50 years old and studies revealed 
that is slightly more frequent in females.
[15,18,19] 
Clinically a PA in the soft palate presents as a 
painless swelling without ulceration or 
surrounding inflammation.
 
The diagnosis of PA is established on the 
basis of history, physical examination, cytology 
and histopathology. Computed tomography 
(CT) scan and magnetic resonance imaging 
(MRI) provide information of the localization, 
size, extension of tumor to the surrounding 
superficial and deep structures. 
The gold standard treatment for PA in minor 
salivary glands is wide local excision with 
removal of periosteum and involved bone. 
Simple enucleation of this tumor leads to high 





A 20-year-old female patient reported to the 
Department of Head and Neck Surgery with the 
chief complaint of a painless swelling on the 
left soft palate (arrow) for the past 6 months 
with a deviation of the uvula (asterisk) (Fig. 1). 
* 
Fig.1. Intraoral examination. Swelling on the left soft 
palate (arrow) with deviation of the uvula (asterisk). 
Fig..2. Intraoral examination revealing a solitary, oval-
shaped, red-colored, circumscribed lesion on the left soft 
palate (arrow), crossing the midline and pushing the 
uvula to the right (asterisk). 
Swelling was insidious in onset and gradually 
increasing in size. The deviation of the uvula 
was what the patient first noticed. There was no 
preceding history of trauma and no relevant 
past medical history. Intraoral examination 
(Fig.2) revealed a solitary, oval-shaped, red-
colored, circumscribed lesion on the left soft 
palate (arrow), crossing the midline and 
pushing the uvula to the right (asterisk), 
measuring approx. 3 x 2 cm. On palpation, 
swelling was soft in consistency with well-
defined borders, non-tender, non-fluctuant, 
non-reducible and non-mobile. The overlying 
mucosa was smooth and intact. The 
submandibular lymph nodes on the left side 
were enlarged, painless and movable. Her 
general physical and systemic examination was 
normal. 
Clinical differential diagnoses of lipoma, 
benign tumors, such as the pleomorphic 
adenoma were considered, as well as malignant 
tumors, such as the mucoepidermoid car-
cinoma, adenoid cystic carcinoma and the 
polymorphous low-grade adenocarcinoma. 
Contrast-enhanced computed tomography 
(Fig. 3) revealed a well-circumscribed hypo-
dense mass, situated in the soft palate on the 
left side, measuring approximately 46 x 32 mm 
in the transverse plane with a cranio-caudal 
diameter of 51 mm. The mass was somewhat 
heterogeneous with an extensive cystic/necrotic 
constitution. It developed through the 
parapharyngeal space and extended into the left 
carotid space and it was invading the jaw 
muscles, namely the medial pterygoid. The 
mass was also growing for the naso and 
oropharynx, pushing the airway slightly to the 
right. Fine-needle aspiration (FNA) cytology 
showed morphology compatible with a 
primitive epithelial-myoepithelial salivary 
gland tumor, with chondromyxoid fibrillary 
stroma, suggestive of a pleomorphic adenoma. 
A wide excision of the lesion was performed 
along with curettage of underlying bone, under 
general anesthesia. The whole tumor mass was 
separated out with careful dissection of the 
carotid space. The specimen was sent for 
histopathological examination (Figs. 4a, 4b, 4c, 
4d). Macroscopic description showed a surgical 
specimen of tumorectomy with 34 g and 50 x 
40 x 20 mm, consisting of a capsulated nodular 
tumor, whose surface section is pearly and 
* 
Fig..3. Contrast-enhanced computed tomography revea-
ling a well-circumscribed hypodense mass, situated on 
the left soft palate (asterisk). 
* 
* 
Fig..4. Pleomorphic adenoma. Histology showed an en capsulated (arrow) multinodular tumor (Fig. 4a) with a 
tubular and ductular pattern (parentheses) in a myxoid stroma (asterisk) (Fig. 4b, 4c) and a chondromyxoid stroma 
(Fig. 4b, 4d). 
Fig. 5. Postoperative. 
elastic, with myxoid areas. Histology showed 
an encapsulated multinodular tumor (Fig. 4a) 
with a tubular and ductular pattern in a myxoid 
stroma (Fig. 4b, 4c) and with a chondromyxoid 
stroma (Fig. 4b, 4d).  
The result was in agreement with the 
specimen taken before the surgery and 
confirmed the diagnosis of pleomorphic 
adenoma. The entire lesion was excised, with 
juxta-lesional margins. 
There were no postoperative (Fig. 5) 
complications, and no recurrence was seen 
during the 3 years follow-up period. The 
patient is still under regular follow-ups.  
 
DISCUSSION 
We report the case of a patient with PA who 
was successfully treated to full recovery.  In 













several fundamental questions concerning this 
particular adenoma are still open. 
Macroscopy. PA tend to form well-defined, 
ovoid or round tumors. They are often 
encapsulated but the capsule varies in thickness 
and may be partially or completely absent, 
particularly in predominantly mucoid tumors. 
Those PAs developing in the minor glands 
usually have a poorly developed or absent 
capsule. The outer surface of larger tumors is 
frequently bossellated. The cut surface is 
typically homogeneous and white or tan. It may 
have a glistening appearance where there are 
cartilaginous or myxochondroid areas.
[22]
 
Histology. Histologically, PAs contain 
groups of epithelial and myoepithelial cells in 
varying stages of organization. The proportion 
of each of these elements varies widely and one 
or the other is often predominant.
[13]
 The 
essential components are the capsule, epithelial 
and myoepithelial cells, and mesenchymal or 
stromal elements. The epithelium usually forms 
sheets or duct-like structures. The ducts show 
cuboidal luminal cells and there may be an 
abluminal layer of myoepithelial cells. The 
mesenchymal-like component is mucoid/ 
myxoid, cartilaginous or hyalinized and 
sometimes this tissue forms the bulk of the 
tumor. The cartilage-like material appears to be 
true cartilage and is positive for type II 
collagen and keratin sulphate.
[22]
  Some long-
standing tumors show increasing hyalinization 
and the epithelial component is progressively 
effaced. Bone may form within this cartilage or 
form by osseous metaplasia of the stroma. The 
myoepithelial cells frequently separate from the 
epithelial nests and give rise to a 
chondromyxoid or hyalinized stroma. Thus, the 
demarcation between epithelial nests and 
stromal cells may be indistinct, as 
myoepithelial cells appear to drop off from the 
epithelial nests.
[23]
 The presence of 
chondromyxoid matrix material is the most 
specific feature for making the correct 
diagnosis.
[16] 
Most tumors show areas where 
finger-like processes extend into the capsule. 
Histogenesis. The histogenesis process of 
PA of salivary gland continues to remain a 
controversial subject. While some authors 
suggest the origin of the two tumoral 
components (parenchyma and stroma) from 
different sources, mesenchymal and 
myo(epithelial), the majority confirms and 
proves the unicellular origin of this tumor from 
the epithelial cells. 
[9,10,13,14,17]
 Enescu et al
[9]
, 
demonstrated the existence of an epithelial-
mesenchymal transition process in PA, using 
the reactivity for E-cadherin and α-SMA 
(alpha-smooth muscle actin) expression, 
showing the process through which the 
epithelial neoplastic cells transdifferentiate into 
mesenchymal cells. Satpathy et al
[14]
 showed an 
important role of mucins in cancer 
development and invasion. Like normal 
epithelial tissue, cancer cells use mucins to 
control the environment, regulate 
differentiation and proliferation and enhance 
invasive and metastatic properties. They 
confirmed the role of myoepithelial cells in 
stromal histogenesis. The neoplastic 
myoepithelial cells differentiate to stellate cells, 
which produce the myxoid matrix, and they 
further differentiate into chondroblastic cells, 
which develop cartilaginous areas by 
synthetizing mucopolysaccharides. They also 
noted the change in mucin profile from neutral 
mucins to acidic mucins as the neoplasm 
progresses. Matsumoto et al
[12]
, studied the 
mechanism behind chondrogenesis, examining 
the expression of transcription factors related to 
chondrogenesis in tumors and salivary glands. 
This study provided indirect but conclusive 
evidence that epithelial cells differentiate to 
chondrocytes during tumorigenesis of salivary 
gland PA, indicating that salivary gland cells 
have potential for chondrogenesis. This model 
predicts that Twist1 (a member of the basic 
helix-loop-helix family of transcription factors) 
expression prevents salivary gland cells from 
fulfilling the chondrogenic potential, and 
Twist1 depletion concomitant with neoplastic 
transformation permits them to differentiate 
toward chondrocytes and produce cartilage-like 
mesenchymal tissues in PA. 
Chromosomal alterations. PA has been 
associated with abnormal karyotypes in up to 
70% of cases,
[21, 22]
 with nonrandom invol-
vement of 8q12, the locus of the pleomorphic 
adenoma (PLAG1) gene. However, PLAG1 has 
also be shown to be activated in cases of PA 
either with normal karyotypes or with 12q13-
15 abnormalities. The PLAG1 protein is a 
nuclear oncoprotein that functions as a DNA-
binding transcription factor. Downregulation of 
PLAG1 target genes, including IGF2 (insulin-
like growth factor 2), is likely to play a major 
role in the genesis of PA. 
[22]
 The trisomy 8 is 
known to be the most frequent numerical 
deviation found in salivary gland tumors, being 
present in benign and malignant tumors. The 
mechanisms associated with gain of 
chromosomes are still unclear; the most 
plausible explanation is that gene dosage 
alterations predispose to tumor proliferation.
[10]
 
Previous studies have indicated that patients 
with karyotypically normal adenomas are 
significantly older than those with 
rearrangements of 8q12 and that adenomas 
with normal karyotypes are often more stroma 
rich than tumors with 8q12 abnormalities. 
[22]
 
Clinical course. Clinically PA presents as a 
slow-growing, asymptomatic, painless, 
unilateral firm mass with a normal overlying 
surface color, that may become large if is 
untreated. Pain, tenderness and ulceration are 
unusual. When originating in the minor salivary 
glands, in most cases it occurs in the soft and 
hard palate due to the highest concentration of 
salivary glands there and is typically a firm or 
rubbery submucosal mass without ulceration or 
surrounding ulceration.
[13,20]
 The more common 
palatal mixed tumors are located laterally and 
rarely cross the midline.
[14]
 Symptoms due to 
more advanced minor salivary gland tumors 
can include nasal obstruction, congestion, 
vision changes, or trismus when present in the 
nasal cavity or maxillary sinus. Minor salivary 
gland tumors involving the nasopharynx 
usually present at an advanced stage and 
invasion of the skull base, intracranial 
extension, or involvement of cranial nerves can 
occur.
[5]
 In contrast, malignant lesions exhibit 
fast growth and adhere to deep layers, with an 
ulcerated or telangiectatic surface. Pain is the 
most suggestive characteristic of malignancy.
[4]
 
Diagnosis by histopathology. Histopatho-
logical sampling procedures include fine needle 
aspiration cytology (FNAC) and core needle 
biopsy (bigger needle compared to FNA). FNA 
operated in experienced hands, can determine 
whether the tumor is malignant in nature with 
90% sensivity. FNA can also distinguish 
primary salivary tumor from metastatic disease. 
By the fact that PA has different histological 
characteristics in some situations, the diagnosis 
of these lesions, after FNAC, can be interpreted 
wrongly.
[19]
 Core needle biopsy is more 
invasive but it is more accurate compared to 
FNA with diagnostic accuracy greater than 
97%.
[17,24]
 False positive and false negative 
rates of FNAC range from 1 to 14%.
[16]
 
Diagnosis by imaging methods. The role of 
imaging studies is to differentiate neoplastic 
from benign disease, define intra- versus extra-
glandular location, assess local extension and 
invasion, and detect nodal and systemic 
metastases. CT with intravenous contrast is 
widely used to detect bone invasion, thus it is 
superior to MRI in evaluating bone, especially 
in diagnosing erosion and perforation of the 
bony palate and possible involvement of the 
nasal cavity or maxillary sinus. MRI, with its 
high resolution for soft tissue, provides better 
definition of the vertical and inferior tumor 
extension through its multiplanar capacity and 
the tumor-muscle interface and more clearly 
indicates the degree of encapsulation.
[17,25]
 MRI 
is suggested in evaluation of all sublingual 
gland tumors given the high risk for malignant 
disease.
[5]
 Both can provide the extension of a 
SGT and anatomic details that are useful for 
surgical planning. Ultrasound is also frequently 
used to guide FNA or core needle biopsy.
[24]
 
Staging and therapy of salivary gland 
tumors. Malignancies of the parotid, subman-
dibular, and sublingual glands are staged 
according to the American Joint Committee on 
Cancer (AJCC) and the International Union for 
Cancer Control Tumor, Nodes, Metastasis 
(TNM) system. Tumors arising in minor 
salivary glands are staged according to their 
anatomic site of origin.
[5]
 
The mainstay of the treatment for SGT is a 
complete surgical resection with a surrounding 
cuff of normal tissue. The excision should 
include periosteum or bone if this are 
included.
[6,24]
 Every attempt should be made to 
ensure negative resection margins, since 
positive margins are associated with worse 
prognosis.
[25]
 Some studies demonstrate that 
PA has occasionally lack of encapsulation and 
pseudopodia.
[13]
 So although most PAs are 
encapsulated or at least circumscribed, simple 
enucleation of a PA is frequently associated 
with local recurrence. According to Debnath et 
al
 [24]
, if complete resection cannot be achieved, 
adjuvant radiotherapy should be added to 
improve local control. In this case, the surgical 
resection with a surrounding cuff of normal 
tissue was possible in almost all tumor’s 
surrounding area, except the tumor’s margin 
next to the carotid space due to its proximity. 
But it was possible to do a complete extraction 
of the capsule without disruption and no 
radiotherapy was advocated. 
Enucleation of PA leads to a high recurrence 
rate, so it should be avoided. Surgical exposure 
of the tumor or tumor capsule risks spillage and 
dramatically increases the risk of recurrence, 
but PAs of the minor salivary glands have little 
propensity for recurrence (a recurrence rate of 2 
to 44%, but mainly of the parotid gland).
[13]
  
Inadequate surgical procedure was reported to 
be the main cause of failure. The most frequent 
surgical issues are pseudopodia, capsular 
penetration, rupture of tumors and multi 
nodularity.  
Potential for malignancy. While PA is 
considered pathologically and clinically benign, 
it can undergo malignant transformation in situ, 
termed “carcinoma ex-pleomorphic adenoma” 
(CaExPA), with an incidence of 2 to 7% of 
PAs.
[8,23,24]
 This may be manifested by sudden 
growth of a previously stable mass in a salivary 
gland, usually the parotid. The prognosis of a 
carcinoma arising within a PA is largely but not 
entirely dependent upon the extent of invasion. 
Cases where the carcinoma component was 
confined within the tumor capsule have not 
recurred or metastasized, in contrast to the 
aggressive behavior seen with invasive 
CaExPA. Other prognostic factors include 
grade, tumor size and lymph node status. 
Frequent local recurrences and distant 
metastases mark the clinical course of invasive 
CaExPA. Therefore CaExPA should be 
considered a high-grade malignancy requiring 
treatment at the initial diagnosis, as subsequent 





, demonstrated that WIF1 (Wnt 
inhibitory factor 1) downregulation is a 
widespread event in human salivary gland 
CaExPa. WIF1 downregulation occurs at a high 
frequency in PAs that have progressed to 
CaExPa, but is rare in PAs that have not 
progressed to malignancy. Therefore, it was 
suggested that WIF1 expression could be 
considered in routine histopathology analysis of 
PA samples, as it might indicate a higher risk 
of progression from PA to CaExPa.  
A much rarer phenomenon can also occur 
whereby a PA demonstrates clinically ma-
lignant behavior while remaining histologically 
benign, termed metastatic pleomorphic 
adenoma (MPA).
[8,13,16,19]
 It can metastasize as 
long as 7 years
[26]
 or even 24 years later.
[8]
 
Patients at risk of MPA have a history of 
recurrent or incomplete treated PA, and as no 
current molecular or histological parameters 
can predict the development of MPA, such 
patients should be considered for screening for 
metastatic disease.
[8]
 Recurrences are rare in the 
minor glands and appear to be much more 
likely in younger patients. 
[22]
 
Hence, the long term follow up becomes 
imperative to evaluate possible recurrences, 
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